NCT01287806|UnknownPhase 2
Ulinastatin in Inhalation Lung Injury
Multicenter,Randomized,Parallel Assignment,Blank Control Study of Ulinastatin in Inhalation Lung Injury
Loading search results
Multicenter,Randomized,Parallel Assignment,Blank Control Study of Ulinastatin in Inhalation Lung Injury
Sponsor study identifier
interventional
120
1 country
1
Study Start
February 2011
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
December 2012
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
January 2013
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
The purpose of this study is to evaluate the efficacy and effect of ulinastatin in inhalation lung injury patients.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
January 2013
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
January 24, 2011
Actual (reported)February 2011
Date type not reportedThis date has not been verified as actual or estimated.
February 1, 2011
Actual (reported)December 2012
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
January 2013
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
all cause mortality
until death or discharge from hospital, data reviewed every 3 months
length of mechanical ventilation
from admission to 90 days
length of ICU stay
until death or discharge from hospital, data reviewed every 3 months
length of hospital stays
until death or discharge from hospital, data reviewed every 3 months
blood inflammatory mediator
0days,5days and 10days
Bronchoscopy morphological evaluation
0days,5days and 10days
ulinastatin is a multivalent kunitz-type serine protease inhibitor refined from human urine
Resolved 4 vials of drugs in 100ml physiological saline solution,intravenously infused for 1-2h,tid,for continuous 10days
standard treatment
304 hospital of PLA
Beijin, Beijin, 100000, China
sheng zhiyong, MD
First Hospitals affiliated to the China PLA General Hospital
Jia chiyu, MD
First Hospitals affiliated to the China PLA General Hospital
Xia zhaofan, MD
Changhai Hospital
Pang yizhi, MD
Southwest Hospital, China
First Submitted
January 24, 2011
First Posted
February 1, 2011
Study Start
February 2011
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
December 2012
Estimated (date passed)Intermittent-pneumatic Compression in Inhalation-injury Children: Effects on Diaphragm Mobility and Pulmonary Function
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to confirm eligibility.
Chen tunhu, MD
General Hospital of Jinan PLA Military Region
Zhu jinmin, MD
General Hospital of Beijing PLA Military Region
Liu yi, MD
General Hospital of Lanzhou PLA Military Region
Cui xiaolin, MD
Liaonin People's Armed Police Corps Hospital
Sheng guanyu, MD
187 Central Hospital of the Chinese PLA
Lu qinjun, MD
251 Central Hospital of the Chinese PLA
Shi shengfu, MD
322 Central Hospital of the Chinese PLA
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
January 2013
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
February 1, 2011
Record last verified: 2011-01
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: